New York State Common Retirement Fund’s aTyr Pharma ATYR Stock Holding History

New York State Common Retirement Fund’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27,500	Closed	-$21.4K	–	3346
2026 Q1	$21.4K	Hold	27,500	–	–	﹤0.01%	3005
2025 Q4	$21.5K	Hold	27,500	–	–	﹤0.01%	3078
2025 Q3	$19.8K	Hold	27,500	–	–	﹤0.01%	3108
2025 Q2	$139K	Buy	+27,500	New	+$108K	﹤0.01%	2412
2016 Q3	–	Sell	-393	Closed	-$15K	–	3164
2016 Q2	$15K	Hold	393	–	–	﹤0.01%	3153
2016 Q1	$22K	Hold	393	–	–	﹤0.01%	3115
2015 Q4	$54K	Hold	393	–	–	﹤0.01%	3103
2015 Q3	$56K	Buy	393 +113	+40%	+$25.8K	﹤0.01%	3108
2015 Q2	$73K	Buy	+280	New	+$87K	﹤0.01%	3165

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New York State Common Retirement Fund's ATYR Position: Q2 2026 in Review

New York State Common Retirement Fund sold out of aTyr Pharma (ATYR) in Q2 2026, closing a stake of 27,500 shares — an estimated $21.4K sold.

New York State Common Retirement Fund first reported a position in ATYR in Q2 2015 and held it in 9 quarters. The position peaked at $139K in Q2 2025. 89 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

New York State Common Retirement Fund reported no remaining aTyr Pharma position as of Q2 2026 after selling out during the quarter.
New York State Common Retirement Fund sold 27,500 aTyr Pharma shares in Q2 2026, an estimated $21.4K.
New York State Common Retirement Fund first reported a position in aTyr Pharma in Q2 2015 and held it in 9 quarters.
New York State Common Retirement Fund's aTyr Pharma position peaked at $139K in Q2 2025.
89 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.